Suchergebnisse - (Person:"Zhou, Zhiguang")

PubPharm (7)

1

Efficacy and safety of fixed-ratio combination insulin degludec/liraglutide in type 2 diabetes : A systematic review and meta-analysis of randomised controlled trials

enthalten in: Diabetes/metabolism research and reviews | 2024

von Wang, R. | Luo, S. | Xiao, Z. | +1

2

The continuous spectrum of glycaemic variability changes with pancreatic islet function : A multicentre cross-sectional study in China

enthalten in: Diabetes/metabolism research and reviews | 2022

von Zhang, L. | Guo, K. | Tian, Q. | +14

3

Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus

enthalten in: Diabetes, obesity & metabolism | 2022

von Wang, W. | Song, X. | Lou, Y. | +3

4

Observational study evaluating the effectiveness of physician-targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II)

enthalten in: Journal of diabetes | 2020

von Weng, J. | Zhao, J. | Zhou, Z. | +19

5

Dapagliflozin as add-on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs : A randomized controlled trial

enthalten in: Journal of diabetes | 2018

von Yang, W. | Ma, J. | Li, Y. | +5

6

Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs : Real-life use of basal insulin in China

enthalten in: Diabetes, obesity & metabolism | 2017

von Ji, L. | Zhang, P. | Zhu, D. | +13

7

Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY) : a multicenter, randomized, controlled, non-inferiority clinical trial

enthalten in: Science China. Life sciences | 2017

von Xu, W. | Mu, Y. | Zhao, J. | +15

CommentIn: Sci China Life Sci. 2017 Mar;60(3):319-320. - PMID 28271252

1
[1]